Foxconn Bets on Healthcare Robotics With $30M Robocore Investment
Foxconn is stepping further into healthcare technology with a new bet on medical robotics. The electronics giant has committed up to $30 million to Robocore, a company known for developing service robots that are increasingly used in hospitals, elder care, and retail. The investment, made through Foxconn’s subsidiary Q-Run Holdings, highlights the company’s effort to expand beyond manufacturing into fast-growing fields powered by AI and robotics.
The deal begins with an initial $10 million investment in preferred shares , giving Foxconn a 6.6% stake in Robocore’s RoboTemi Global unit. Two more tranches of $10 million each could follow over the next two years, depending on performance reviews. For Robocore, the fresh capital will fuel expansion in telemedicine across the US, Europe, and Japan, support new consumer product launches in China, and strengthen its international sales and marketing operations.
Robocore is already present in nearly 20,000 locations worldwide , including more than 5,000 sites in the US. Its “temi” robots are used to assist doctors and caregivers, run remote diagnostics, and support patients in hospitals and nursing homes. In New York state alone, over 200 senior care facilities use the robots to carry out two-minute health checks, reducing costs and improving access to medical services.
Looking ahead, Robocore expects to triple its revenue within three years and grow fivefold by 2028. The company is also preparing for a potential IPO within the next five years, aiming to establish itself as a leader in the global medical robotics market. For Foxconn, the move signals a strategic shift: from its roots in electronics manufacturing toward becoming a player in the future of healthcare technology.
Source:
A.M.
